tetano
Editor, Senior Moderator
Front Immunol
. 2026 Aug 20:17:1907275.
doi: 10.3389/fimmu.2026.1907275. eCollection 2026.
Jan Niklas Thon 1 , Judith Schenz 1 , Mascha Onida Fiedler 1 , Uta Merle 2 , Monica Boxberger 2 , Florian Uhle 1 , Markus Alexander Weigand 1 3 , Dominik Schaack 1 , Benedikt Hermann Siegler 1
Affiliations Expand
Introduction: Severe COVID-19 is associated with innate immune dysregulation resembling sepsis-induced immunoparalysis. Epigenetic mechanisms, particularly changes in H3K4me3 enrichment at gene promoters, have been observed in immune tolerance and monocyte dysfunction in sepsis. Whether comparable H3K4me3 alterations occur during acute critical COVID-19 illness has not been investigated.
Methods: In this prospective single-center study, 46 hospitalized COVID-19 patients were enrolled, of whom 27 were treated in the intensive care unit (ICU group) and 19 on the normal ward (non-ICU group). Genome-wide H3K4me3 ChIP-seq was performed on PBMCs at hospital admission (T1) in the total cohort and after seven days (T2) in the ICU group. Monocyte HLA-DR expression and ex vivo TLR-stimulated cytokine secretion were assessed as functional immune readouts.
Results: Among 706 differentially bound consensus peaks with promoter association between ICU and non-ICU groups, 704 showed increased H3K4me3 occupancy in ICU patients, predominantly at neutrophil effector gene loci, supported by pathway enrichment of neutrophil degranulation and innate immune activation. Monocyte HLA-DR expression and ex vivo TLR-stimulated IL-6 secretion were persistently reduced throughout the first week of ICU treatment. Longitudinal profiling in the ICU group revealed a shift from an interferon-driven chromatin signature at admission toward sustained innate immune activation and ECM remodeling at day seven.
Conclusion: This study provides the first genome-wide H3K4me3 characterization of circulating immune cells during acute critical COVID-19, demonstrating that epigenetic reprogramming is an active and dynamic process that mirrors the functional immune dysregulation observed in these patients.
Keywords: COVID-19; H3K4me3; SARS-CoV-2; epigenetics; histone modifications; neutrophil hyperactivation; sepsis.
. 2026 Aug 20:17:1907275.
doi: 10.3389/fimmu.2026.1907275. eCollection 2026.
Genome-wide H3K4me3 profiling of circulating immune cells reveals dynamic epigenetic reprogramming during acute critical COVID-19
Jan Niklas Thon 1 , Judith Schenz 1 , Mascha Onida Fiedler 1 , Uta Merle 2 , Monica Boxberger 2 , Florian Uhle 1 , Markus Alexander Weigand 1 3 , Dominik Schaack 1 , Benedikt Hermann Siegler 1
Affiliations Expand
- PMID: 42694164
- PMCID: PMC13538114
- DOI: 10.3389/fimmu.2026.1907275
Abstract
Introduction: Severe COVID-19 is associated with innate immune dysregulation resembling sepsis-induced immunoparalysis. Epigenetic mechanisms, particularly changes in H3K4me3 enrichment at gene promoters, have been observed in immune tolerance and monocyte dysfunction in sepsis. Whether comparable H3K4me3 alterations occur during acute critical COVID-19 illness has not been investigated.
Methods: In this prospective single-center study, 46 hospitalized COVID-19 patients were enrolled, of whom 27 were treated in the intensive care unit (ICU group) and 19 on the normal ward (non-ICU group). Genome-wide H3K4me3 ChIP-seq was performed on PBMCs at hospital admission (T1) in the total cohort and after seven days (T2) in the ICU group. Monocyte HLA-DR expression and ex vivo TLR-stimulated cytokine secretion were assessed as functional immune readouts.
Results: Among 706 differentially bound consensus peaks with promoter association between ICU and non-ICU groups, 704 showed increased H3K4me3 occupancy in ICU patients, predominantly at neutrophil effector gene loci, supported by pathway enrichment of neutrophil degranulation and innate immune activation. Monocyte HLA-DR expression and ex vivo TLR-stimulated IL-6 secretion were persistently reduced throughout the first week of ICU treatment. Longitudinal profiling in the ICU group revealed a shift from an interferon-driven chromatin signature at admission toward sustained innate immune activation and ECM remodeling at day seven.
Conclusion: This study provides the first genome-wide H3K4me3 characterization of circulating immune cells during acute critical COVID-19, demonstrating that epigenetic reprogramming is an active and dynamic process that mirrors the functional immune dysregulation observed in these patients.
Keywords: COVID-19; H3K4me3; SARS-CoV-2; epigenetics; histone modifications; neutrophil hyperactivation; sepsis.